We aren’t the only ones talking about TMS.

News & Press

FDA Permits Marketing of TMS for Obsessive Compulsive Disorder

Today, the U.S. Food and Drug Administration permitted marketing of the Brainsway Deep Transcranial Magnetic Stimulation System for treatment of obsessive compulsive disorder (OCD). “Transcranial magnetic stimulation has shown its potential to help patients suffering from depression and headaches,” said Carlos Peña, Ph.D., M.S., director of the Division of Neurological and Physical Medicine Devices in…

Read more

More Reading

TMS is not painful

Is TMS Painful?

Major depressive disorder (MDD) can be debilitating and painful both emotionally and physically, filling the body with aches, tension and unexplained pains. The last thing a person with depression wants to do is to add more pain into their lives; there is a need for a treatment such as TMS that is localized, harmless and…

Read more

Insurance Coverage for TMS

Within California* and Oregon, Transcranial Magnetic Stimulation has been approved for use with treatment resistant depression by several insurance providers. Insurances that we’re in network with include Optum, Magellan, Anthem Blue Cross, Cigna, Aetna, Regence and Tricare. We also have single case agreements with MHN. Please call us for a full list of providers. We would be happy to help check with your insurance regarding pre-approval.

*Unfortunately, Medi-cal currently does not cover TMS treatment in California. Please contact your Medi-cal provider to inquire further.

APA

CTS